Humulin N Suspension For Injection 100U Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Humulin N: Suspension for injection (100U)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png
Humulin N 100u/ml Susp for Inj
Drug Image file default-drug-image.png
Humulin N Pen Susp for Inj
Drug Image file default-drug-image.png
Humulin N Pen Susp for Inj
Drug Image file default-drug-image.png
Humulin N 100u/ml Susp for Inj

What is this Medicine?

ISOPHANE INSULIN (NPH) (EYE soe fane IN su lin) is a human-made form of insulin. This medicine lowers the amount of sugar in the blood. It is an intermediate-acting insulin that starts working about 1.5 hours after it is injected.

CVS Pharmacy Patient Statistics for Humulin N: Suspension for injection(100U)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

Humulin N 100unit/ml Suspension for Injection

NDC: 000028315
  • Over the Counter
    (Prescription Not Required)
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus, Gestational Diabetes

Storage Information
Avoid exposure to heat
Protect from light
Store in refrigerator (36 to 46 degrees F) or at room temperature, not to exceed 86 degrees F
Store opened (in use) product at room temperature (below 86 degrees F), discard unused product after 31 days
Protect from freezing
Humulin N 100unit/ml Suspension for Injection

Reported Side Effects for Humulin N 100unit/ml Suspension for Injection

Severe Low Blood Sugar Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Anaphylactoid Reactions Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Skin Rash Incidence:
1.0-10.0%*
Severity: MILD
Onset: EARLY
Headache Incidence:
5.0-10.0%*
Severity: MILD
Onset: EARLY
Low Blood Sugar Incidence:
>10.0%*
Severity: MODERATE
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

SECOND Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THIRD Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Compatible - This drug is generally safe to take by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Humulin N

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.